glyburide has been researched along with Diffuse Parenchymal Lung Disease in 1 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zuccarini, G | 1 |
| Bocchino, M | 1 |
| Assante, LR | 1 |
| Rea, G | 1 |
| Sanduzzi, A | 1 |
1 other study available for glyburide and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Metformin/glibenclamide-related interstitial lung disease: a case report.
Topics: Administration, Oral; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Substitution; | 2014 |